CY1117248T1 - COMPOSITIONS AND METHODS FOR SUSPENSION OF JAK ROAD - Google Patents

COMPOSITIONS AND METHODS FOR SUSPENSION OF JAK ROAD

Info

Publication number
CY1117248T1
CY1117248T1 CY20151101115T CY151101115T CY1117248T1 CY 1117248 T1 CY1117248 T1 CY 1117248T1 CY 20151101115 T CY20151101115 T CY 20151101115T CY 151101115 T CY151101115 T CY 151101115T CY 1117248 T1 CY1117248 T1 CY 1117248T1
Authority
CY
Cyprus
Prior art keywords
compositions
jak
methods
road
suspension
Prior art date
Application number
CY20151101115T
Other languages
Greek (el)
Inventor
Hui Li
Thilo J Heckrodt
Yan Chen
Darren John Mcmurtrie
Vanessa Taylor
Rajinder Singh
Pingyu Ding
Sambaiah Thota
Rose Yen
Original Assignee
Rigel Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10701189.2A external-priority patent/EP2389372B1/en
Application filed by Rigel Pharmaceuticals, Inc. filed Critical Rigel Pharmaceuticals, Inc.
Publication of CY1117248T1 publication Critical patent/CY1117248T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αποκαλύπτονται ενώσεις του τύπου I, συνθέσεις που τις περιέχουν, και μέθοδοι χρήσεως για τις ενώσεις και συνθέσεις για την θεραπεία καταστάσεων, στις οποίες η ρύθμιση της οδού JAK ή η αναστολή των κινασών JAK, ειδικότερα της JAK2 και JAK3, είναι θεραπευτικά χρήσιμη.Compounds of formula I, compositions containing them, and methods of use for the compounds and compositions for the treatment of conditions in which the regulation of the JAK pathway or the inhibition of JAK kinases, in particular JAK2 and JAK3, are therapeutically useful.

CY20151101115T 2009-01-23 2015-12-08 COMPOSITIONS AND METHODS FOR SUSPENSION OF JAK ROAD CY1117248T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14705909A 2009-01-23 2009-01-23
US24163009A 2009-09-11 2009-09-11
EP10701189.2A EP2389372B1 (en) 2009-01-23 2010-01-22 Compositions and methods for inhibition of the jak pathway

Publications (1)

Publication Number Publication Date
CY1117248T1 true CY1117248T1 (en) 2017-04-05

Family

ID=58461531

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141100439T CY1115187T1 (en) 2009-01-23 2014-06-18 COMPOSITIONS AND METHODS FOR JAK ROAD SUSPENSION
CY20151101115T CY1117248T1 (en) 2009-01-23 2015-12-08 COMPOSITIONS AND METHODS FOR SUSPENSION OF JAK ROAD

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20141100439T CY1115187T1 (en) 2009-01-23 2014-06-18 COMPOSITIONS AND METHODS FOR JAK ROAD SUSPENSION

Country Status (1)

Country Link
CY (2) CY1115187T1 (en)

Also Published As

Publication number Publication date
CY1115187T1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
MX2011007750A (en) Compositions and methods for inhibition of the jak pathway.
CY1118771T1 (en) Macrocyclic derivatives for the treatment of hyperplastic diseases
CY1119534T1 (en) Phosphorus derivatives as kinase inhibitors
CY1117197T1 (en) TRIAZOLOPYRIDINE COMPOUNDS AS RIM kinase inhibitors
MX2020009397A (en) Compositions and methods for inhibition of the jak pathway.
CY1119778T1 (en) PYROLINYL ACRYLAMIDES [2,3-D] PYRIMININYL, PYROLIN [2,3-B] PYRASINYLI AND PYROLINYL [2,3-D] Pyrrolidinyl
CY1118969T1 (en) Pyrimidine-2-amine compounds and their use as JAK kinase inhibitors
CY1118129T1 (en) 5-ALKYNYL-PYRIMIDINES
ATE522536T1 (en) PYRROLOPYRAZINE KINASE INHIBITORS
MX2013001970A (en) Pyrrolopyrimidine compounds and uses thereof.
DK2089369T3 (en) 2,4-Pyrimidinediamine Derivatives as Inhibitors of JAK Kinases for the Treatment of Autoimmune Diseases
TW200942543A (en) Pyrrolopyrazine kinase inhibitors
CR20110028A (en) PIRIMIDINE DERIVATIVES AS CINASE INHIBITORS
MX2012002542A (en) Compounds and compositions as protein kinase inhibitors.
MX2010008198A (en) Pyrrolopyrazine kinase inhibitors.
WO2009132202A3 (en) Macrocyclic compounds and their use as kinase inhibitors
MX2009010728A (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors.
MX2010003366A (en) Piperidine and piperazine derivatives for treating tumours.
WO2007098507A3 (en) Compositions and methods for inhibition of the jak pathway
MY156727A (en) N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
DOP2006000061A (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
UA109775C2 (en) N-containing heteroaryl derivatives as JAK3 kinase inhibitors
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
ATE522534T1 (en) PYRROLOPYRAZINE KINASE INHIBITORS
EA201270535A1 (en) PURINE DERIVATIVES APPLICABLE AS HSP90 INHIBITORS